Skip to main content
69°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
56.42
+0.25 (+0.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Exact Sciences Corporation - Common Stock
< Previous
1
2
3
Next >
Exact Sciences Earns 2025 Great Place To Work® Certification™
May 12, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Participate in May Investor Conference
May 02, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Announces First-Quarter 2025 Results
May 01, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025
April 29, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test
April 22, 2025
From
Exact Sciences Corp.
Via
Business Wire
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups
April 14, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Schedules First Quarter 2025 Earnings Call
April 01, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening
March 31, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner
March 12, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Participate in March Investor Conferences
February 24, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Announces Fourth Quarter 2024 Results
February 19, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Schedules Fourth Quarter 2024 Earnings Call
February 03, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium
January 21, 2025
From
Exact Sciences Corp.
Via
Business Wire
New Evidence Validates Oncodetect's™ Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients
January 21, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Announces Preliminary Fourth Quarter 2024 Results
January 12, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Participate in J.P. Morgan Healthcare Conference
January 02, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Participate in December Investor Conferences
November 26, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024
November 25, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy
November 13, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Announces Third-Quarter 2024 Results
November 05, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Participate in November Investor Conference
November 01, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement
October 27, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Schedules Third Quarter 2024 Earnings Call
October 08, 2024
From
Exact Sciences Corp.
Via
Business Wire
FDA Approves Exact Sciences’ Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening
October 04, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
September 16, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences to Participate in September Investor Conferences
August 28, 2024
From
Exact Sciences Corp.
Via
Business Wire
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
August 23, 2024
Via
AB Newswire
Exposures
COVID-19
Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
August 20, 2024
From
Exact Sciences Corp.
Via
Business Wire
New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion
August 15, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Announces Second-Quarter 2024 Results
July 31, 2024
From
Exact Sciences Corp.
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
